Gilead Sciences Announces First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
JPMorgan Downgrades Gilead Sciences (GILD) to Neutral
May 1, 2020 5:36 AM EDTJPMorgan analyst Cory Kasimov downgraded Gilead Sciences (NASDAQ: GILD) from Overweight to Neutral with a price target of $85.00.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $81.17 yesterday.
... MoreGilead Sciences (GILD) Tops Q1 EPS by 11c
April 30, 2020 4:07 PM EDTGilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.68, $0.11 better than the analyst estimate of $1.57. Revenue for the quarter came in at $5.55 billion versus the consensus estimate of $5.45 billion.
Outlook
There is significant uncertainty about the progression and ultimate impact of the pandemic on Gileads business and operations. While COVID-19 did not materially impact Gileads first quarter results, Gilead... More
